![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Uquifa Mexico S.a. De C.v. Jiutepec Mx, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their significant offerings is Albendazole, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-206 - Rev 00
This Chemical Type CEP, issued on June 25, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1386 associated with this CEP further emphasizes